--- title: "Stereotaxis (STXS) stock listing, news and investor profile" url: "https://aibio.space/companies/stereotaxis/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Stereotaxis, Inc. (NYSE: STXS), United States. Listing facts, related biotech companies and news on aibio.space." --- STXS Stereotaxis, Inc. NYSE · United States # Stereotaxis (STXS) news Stereotaxis, Inc. is a public biotech or pharmaceutical company listed on NYSE under the ticker STXS, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Stereotaxis news We have not published a story on Stereotaxis yet. When there is news, it will appear here. ## Stereotaxis at a glance - **Ticker**: STXS - **Listing**: NYSE - **Country**: United States - **Cash, Jun 30, 2026**: $10.5 million ### Related companies - [Dror Ortho-Design](https://aibio.space/companies/dror-ortho-design/) OTC: DROR - [PyroGenesis Canada](https://aibio.space/companies/pyrogenesis-canada/) OTC: PYRGF - [TransMedics Group](https://aibio.space/companies/transmedics/) NASDAQ: TMDX - [Leef Brands](https://aibio.space/companies/leef-brands/) OTC: LEEEF - [IMMUCELL CORP /DE/](https://aibio.space/companies/immucell-de/) NASDAQ: ICCC - [MERIT MEDICAL SYSTEMS INC](https://aibio.space/companies/merit-medical-systems/) NASDAQ: MMSI - [BIOMERICA INC](https://aibio.space/companies/biomerica/) NASDAQ: BMRA - [WATERS CORP /DE/](https://aibio.space/companies/waters-de/) NYSE: WAT ### Also on NYSE - [Elanco Animal Health](https://aibio.space/companies/elanco-animal-health/) ELAN - [Nuvation Bio](https://aibio.space/companies/nuvation-bio/) NUVB - [WATERS CORP /DE/](https://aibio.space/companies/waters-de/) WAT - [WEST PHARMACEUTICAL SERVICES INC](https://aibio.space/companies/west-pharmaceutical-services/) WST - [Abbott Laboratories](https://aibio.space/companies/abbott-laboratories/) ABT - [Edwards Lifesciences](https://aibio.space/companies/edwards-lifesciences/) EW ## Stereotaxis annual financials | Line | FY2025 | FY2024 | |---|---|---| | Research and development | [$9.4 million](https://www.sec.gov/Archives/edgar/data/1289340/000149315226009881/) | [$9.8 million](https://www.sec.gov/Archives/edgar/data/1289340/000149315226009881/) | | Net income (loss) | [-$21.6 million](https://www.sec.gov/Archives/edgar/data/1289340/000149315226009881/) | [-$24.0 million](https://www.sec.gov/Archives/edgar/data/1289340/000149315226009881/) | | Cash from operations | [-$13.7 million](https://www.sec.gov/Archives/edgar/data/1289340/000149315226009881/) | [-$8.5 million](https://www.sec.gov/Archives/edgar/data/1289340/000149315226009881/) | | Cash and equivalents | [$13.4 million](https://www.sec.gov/Archives/edgar/data/1289340/000149315226037357/) | [$12.2 million](https://www.sec.gov/Archives/edgar/data/1289340/000149315226009881/) | | Short-term investments | [$0](https://www.sec.gov/Archives/edgar/data/1289340/000149315226037357/) | [$0](https://www.sec.gov/Archives/edgar/data/1289340/000149315225021881/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $10.5 million, plus short-term investments of $0, $10.5 million in all. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Stereotaxis What is the ticker symbol of Stereotaxis? Stereotaxis, Inc. trades under the ticker STXS on NYSE. Where is Stereotaxis listed? Stereotaxis, Inc. is listed on NYSE. Which country or territory is Stereotaxis listed under? Our directory records Stereotaxis, Inc. under United States. Does aibio.space cover Stereotaxis? aibio.space lists Stereotaxis, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. Is Stereotaxis profitable? Stereotaxis, Inc. reported a net loss of $21.6 million for the fiscal year ended Dec 31, 2025, and used $13.7 million of cash in operations, per its annual report to the SEC. How much does Stereotaxis spend on research and development? $9.4 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does Stereotaxis have? $10.5 million in cash and short-term investments at Jun 30, 2026, per its 10-Q. ## Investor discussion: Stereotaxis Members talk about Stereotaxis (STXS). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Stereotaxis, newest first. Each line links the filing it comes from. 1. 2026-07-09 Financings Reported an unregistered sale of its securities. SEC Form 8-K (Items 3.02,7.01,8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1289340/000149315226032598/ex99-1.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NYSE:STXS on TradingView](https://www.tradingview.com/symbols/NYSE-STXS/). ## Listing details Stereotaxis, Inc. is a public biotech or pharmaceutical company listed on NYSE under the ticker STXS, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Stereotaxis, Inc. - **Ticker**: STXS - **Listing**: NYSE - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/stereotaxis/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Stereotaxis (STXS) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/stereotaxis/